Neogen Chemicals Ltd

  • BSE Code : 542665
  • NSE Symbol : NEOGEN
  • ISIN : INE136S01016
  • Industry :CHEMICALS

up-arrow 1,502.50 53.80(3.71%)

Open Price ()

1,450.00

Prev. Close ()

1,448.70

Volume (No’s)

52,560

Market Cap ()

3,963.85

Low Price ()

1,448.70

High Price ()

1,520.80

 

Board Meetings

Start Date End Date Purpose
04-Mar-2026 07-Mar-2026 Preferential Issue of shares & Inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares on preferential basis and other connected matters. Outcome of board meeting approving issue of 1000000 equity shares on preferential issue basis and approving Notice of EGM and related timelines. (As Per BSE Announcement Dated on:07.03.2026)
06-Feb-2026 11-Feb-2026 Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Intimation of Board Meeting to be held on February 11 2026. Outcome of Board meeting approving unaudited financial results of the company for the quarter and nine months ended 31-12-2025. (As per BSE announcement dated on : 11.02.2026)
05-Nov-2025 08-Nov-2025 Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve Intimation of Board meeting to be held on November 8 2025 Outcome of Board meeting (As Per BSE Announcement Dated on 08.11.2025)
30-Jul-2025 02-Aug-2025 Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 inter alia to consider and approve Un-audited standalone and consolidated financial results of the Company for the quarter ended on June 30 2025. Outcome of Board Meeting held on August 2, 2025. (As Per BSE Announcement Dated on: 02/08/2025)
09-Jul-2025 12-Jul-2025 Inter alia, to consider, evaluate and approve the proposal for raising of funds by way of issue of non-convertible debentures through permissible mode(s), subject to such regulatory and other approvals as may be required in this regard. Approval of Board for Fund raising by way of issue of non- convertible debentures and noting of Notice received from BSE. (As Per BSE Announcement dated on 12.07.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew